Ricardo Francisco Allegri
Overview
Explore the profile of Ricardo Francisco Allegri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hernandez M, Chaves H, Allegri R, Calandri I
Dement Neuropsychol
. 2024 Nov;
18:e20240163.
PMID: 39534439
Objective: To explore brain morphometry, hypothesizing that patients with TGA exhibit structural alterations. Methods: A case-control study was performed involving TGA subjects (n=50) and matched healthy controls (n=50). Both groups...
2.
Shen Y, Timsina J, Heo G, Beric A, Ali M, Wang C, et al.
Cell
. 2024 Sep;
187(22):6309-6326.e15.
PMID: 39332414
In this high-throughput proteomic study of autosomal dominant Alzheimer's disease (ADAD), we sought to identify early biomarkers in cerebrospinal fluid (CSF) for disease monitoring and treatment strategies. We examined CSF...
3.
Giussani G, Westenberg E, Garcia-Azorin D, Bianchi E, Yusof Khan A, Allegri R, et al.
Neuroepidemiology
. 2024 Jan;
58(2):120-133.
PMID: 38272015
Introduction: The aim of this systematic review and meta-analysis was to evaluate the prevalence of thirteen neurological manifestations in people affected by COVID-19 during the acute phase and at 3,...
4.
Shen Y, Ali M, Timsina J, Wang C, Do A, Western D, et al.
medRxiv
. 2024 Jan;
PMID: 38260583
Background: To date, there is no high throughput proteomic study in the context of Autosomal Dominant Alzheimer's disease (ADAD). Here, we aimed to characterize early CSF proteome changes in ADAD...
5.
Martinez Canyazo C, Keller G, Helou B, Arruabarrena M, Corvalan N, Carello A, et al.
Dement Neuropsychol
. 2023 Aug;
17:e20220079.
PMID: 37533595
Objectives: To measure the effects of cognitive telerehabilitation on cognition, neuropsychiatric symptoms, and memory strategies in a cohort of patients with mild cognitive impairment. Methods: A sample of 60 patients...
6.
Schultz S, Shirzadi Z, Schultz A, Liu L, Fitzpatrick C, McDade E, et al.
Aging Cell
. 2023 Jun;
22(8):e13871.
PMID: 37291760
Although pathogenic variants in PSEN1 leading to autosomal-dominant Alzheimer disease (ADAD) are highly penetrant, substantial interindividual variability in the rates of cognitive decline and biomarker change are observed in ADAD....
7.
Russo M, Salvat F, Kanevsky A, Allegri R, Sevlever G
J Sci Med Sport
. 2023 Jun;
26(7):345-350.
PMID: 37263829
Objectives: The purpose of this study was to investigate the relationship between on-field post-concussion symptoms reported by athletes, on-field neurological signs reported by a trainer or physician, and/or post-concussion symptoms...
8.
Crivelli L, Calandri I, Suemoto C, Salinas R, Velilla L, Yassuda M, et al.
Alzheimers Dement
. 2023 May;
19(9):4046-4060.
PMID: 37204054
Introduction: Latin American Initiative for Lifestyle Intervention to Prevent Cognitive Decline (LatAm-FINGERS) is the first non-pharmacological multicenter randomized clinical trial (RCT) to prevent cognitive impairment in Latin America (LA). Our...
9.
OConnor A, Rice H, Barnes J, Ryan N, Liu K, Allegri R, et al.
J Neurol Neurosurg Psychiatry
. 2022 Dec;
94(5):403-405.
PMID: 36522155
No abstract available.
10.
Hernandez M, Arena J, Alessandro L, Allegri R, Calandri I
Neurol Clin Pract
. 2022 Nov;
12(4):e35-e48.
PMID: 36382126
Background And Objectives: Transient global amnesia (TGA) is an acute amnestic disorder with unclear pathophysiology. Although considered a benign phenomenon, the possibility of a recurrence is a major concern for...